DJIA 17,113.54 61.81 0.36%
NASDAQ 4,456.02 31.31 0.71%
S&P 500 1,983.53 9.90 0.50%
market minute promo

54.95 0.65 (1.20%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

TEVA $54.95 1.20%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.46
Previous Close $54.30
Daily Range $54.45 - $55.33
52-Week Range $36.26 - $55.33
Market Cap $46.8B
P/E Ratio 36.44
Dividend (Yield) $1.19 (2.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,454,759
Average Daily Volume 4,174,716
Current FY EPS $4.82





Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website:

News & Commentary Rss Feed

Is This Drug Maker’s Stock Too Cheap to Ignore?

Teva Pharmaceutical shares have under performed its sector over the past year. Though the company faces a number of issues, most of the bad news may already be priced into the stock. Given the drug maker also appears to have some intriguing opportunities for future growth, are Teva shares too cheap to ignore?

Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs - Analyst Blog

Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog

UBS Lists 6 Stocks With Positive Catalysts Coming Soon

George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR

In the news: Cuts coming at Microsoft, JP Morgan earnings and Albemarle buys Rockwell

3 Stocks Moving The Drugs Industry Upward

UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler

Will Teva Pharmaceuticals (TEVA) Stock Be Affected By EU Fine?

Teva's Contraceptive Gets Positive CHMP Opinion - Analyst Blog

Glaxo's Two Cancer Drugs Get EU Nod - Analyst Blog

See More TEVA News...

TEVA's Top Competitors

TEVA $54.95 (1.20%)
Current stock: TEVA
JNJ $102.47 (1.18%)
Current stock: JNJ
NVS $89.26 (0.76%)
Current stock: NVS
RHHBY $36.83 (0.30%)
Current stock: RHHBY